Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Richard Gilbertson.

Newcastle AuthorsTitleYearFull text
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Daniel Williamson
Kieran O'Toole
Dr Meryl Lusher
et al.
Epigenetic sub-classification and risk-stratification of medulloblastoma using DNA methylomics2012
Professor Steven Clifford
Professor David Ellison
Dr Richard Gilbertson
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas2012
Professor Steven Clifford
Professor David Ellison
Dr Richard Gilbertson
Molecular subgroups of medulloblastoma: the current consensus2012
Professor David Ellison
Sarah Nicholson
Professor Simon Bailey
Professor Steven Clifford
Dr Richard Gilbertson
et al.
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups2011
Dr Ed Schwalbe
Dr Janet Lindsey
Debbie Straughton
Mike Cole
Dr Hisham Megahed
et al.
Rapid Diagnosis of Medulloblastoma Molecular Subgroups2011
Dr Janet Lindsey
Dr Rebecca Hill
Dr Hisham Megahed
Dr Meryl Lusher
Dr Ed Schwalbe
et al.
TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas2011
Dr Ed Schwalbe
Professor Steven Clifford
Dr Richard Gilbertson
Characteristic Genomic Imbalances in Paediatric Ependyoma; The Importance of Chromosome 1Q Gain2010
Dr Vikki Rand
Professor David Ellison
Dr Richard Gilbertson
Cross-species genomics matches driver mutations and cell compartments to model ependymoma2010
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Meryl Lusher
Kieran O'Toole
Sarah Nicholson
et al.
DNA methylomics identifies clinically significant epigenetic subgroups of medulloblastoma2010
Dr Janet Lindsey
Professor Steven Clifford
Professor David Ellison
Dr Richard Gilbertson
Subtypes of medulloblastoma have distinct developmental origins2010
Dr Vikki Rand
Dr Richard Gilbertson
A comprehensive view of the structure and expression of the ependymoma genome at presentation and relapse2009
Jennifer Anderton
Dr Janet Lindsey
Dr Meryl Lusher
Dr Richard Gilbertson
Professor Simon Bailey
et al.
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A22008
Dr Richard Gilbertson
Dr Vikki Rand
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma2008
Professor Steven Clifford
Dr Meryl Lusher
Dr Janet Lindsey
Dr Jackie Langdon
Dr Richard Gilbertson
et al.
Wnt-pathway medulloblastomas2008
Professor David Ellison
Dr Richard Gilbertson
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children2007
Dr Janet Lindsey
Dr Meryl Lusher
Jennifer Anderton
Dr Richard Gilbertson
Professor David Ellison
et al.
Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma2007
Dr Janet Lindsey
Dr Meryl Lusher
Dr Gordon Strathdee
Robert Brown
Dr Richard Gilbertson
et al.
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours2006
Dr Janet Lindsey
Dr Meryl Lusher
Dr Gordon Strathdee
Dr Richard Gilbertson
Professor Simon Bailey
et al.
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours2006
Dr Richard Gilbertson
Dr Jackie Langdon
Roberto Hernan
Professor Steven Clifford
Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma2006
Professor Steven Clifford
Dr Meryl Lusher
Dr Janet Lindsey
Dr Jackie Langdon
Dr Richard Gilbertson
et al.
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis2006
Dr Christopher Calabrese
Professor Steven Clifford
Dr Richard Gilbertson
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation2005
Dr Christopher Calabrese
Professor Steven Clifford
Dr Richard Gilbertson
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation2005
Professor Steven Clifford
Dr Janet Lindsey
Dr Meryl Lusher
Dr Richard Gilbertson
Professor Andrew Pearson
et al.
Identification of tumour suppressor genes in childhood medulloblastoma by promoter hypermethylation profiling2004
Dr Janet Lindsey
Dr Meryl Lusher
Jennifer Anderton
Professor Simon Bailey
Dr Richard Gilbertson
et al.
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling2004
Professor David Ellison
Dr Helen Lucraft
Dr Richard Gilbertson
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma2004
Dr Adrian Frank
Roberto Hernan
Dr Janet Lindsey
Dr Meryl Lusher
Professor Steven Clifford
et al.
The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma2004
Dr Jackie Langdon
Roberto Hernan
Dr Richard Gilbertson
Professor Steven Clifford
Molecular analysis of the PDGFR alpha-RAS/MAPK pathway in childhood medulloblastoma2003
Dr Richard Gilbertson
Professor Steven Clifford
PDGFRB is overexpressed in metastatic medulloblastoma2003
Professor David Ellison
Dr Helen Lucraft
Dr Richard Gilbertson
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study2003
Professor David Ellison
Professor Steven Clifford
Dr Richard Gilbertson
What's new in neuro-oncology? Recent advances in medulloblastoma2003
Dr Richard Gilbertson
Roberto Hernan
Dr Adrian Frank
Professor David Ellison
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease2002
Emeritus Professor Robert Perry
Dr David Walker
Dr Richard Gilbertson
Professor David Ellison
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation2002
Dr Helen Lucraft
Dr Richard Gilbertson
Results of the SIOP/UKCCSG PNET-3 randomised study of pre-radiotherapy chemotherapy compared with radiotherapy alone in M0/M1 medulloblastoma2002
Dr Richard Gilbertson
Roberto Hernan
Emeritus Professor Robert Perry
Professor John Lunec
Professor Andrew Pearson
et al.
Clinical and molecular stratification of disease risk in medulloblastoma2001
Dr Richard Gilbertson
Professor David Ellison
Molecular stratification of disease risk in childhood medulloblastoma2001
Dr Richard Gilbertson
Roberto Hernan
Professor David Ellison
Emeritus Professor Robert Perry
Professor Andrew Pearson
et al.
Novel ErbB4 juxtamembrane splice variants and the truncated ErbB2 receptor isoform are frequently expressed in childhood medulloblastoma2001
Dr Richard Gilbertson
Roberto Hernan
Professor David Ellison
Emeritus Professor Robert Perry
Professor Andrew Pearson
et al.
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma2001
Dr Richard Gilbertson
Roberto Hernan
Professor Andrew Pearson
Professor John Lunec
Expression and characterisation of novel ErbB-4 alternative spliced variants by childhood1999
Dr Richard Gilbertson
Roberto Hernan
Professor Andrew Pearson
Professor John Lunec
The ErbB2 receptor represents a potential target for novel therapies in childhood medulloblastoma.1999
Dr Richard Gilbertson
Professor Steven Clifford
Dr Christopher Wright
Emeritus Professor Robert Perry
Professor Andrew Pearson
et al.
Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma1998
Dr Richard Gilbertson
Dr Evelyn Jaros
Emeritus Professor Robert Perry
Professor John Lunec
Professor Andrew Pearson
et al.
Mitotic percentage index: A new prognostic factor for childhood medulloblastoma1997
Dr Richard Gilbertson
Emeritus Professor Robert Perry
Professor Andrew Pearson
Professor John Lunec
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma1997
Dr Richard Gilbertson
Dr Evelyn Jaros
Professor John Lunec
Professor Andrew Pearson
The epidermal growth factor receptor (EGFR) family and childhood medulloblastoma1997
Dr Richard Gilbertson
Professor Andrew Pearson
Emeritus Professor Robert Perry
Dr Evelyn Jaros
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma1995
Dr Richard Gilbertson
Dr Evelyn Jaros
Emeritus Professor Robert Perry
Professor Andrew Pearson
Prognostic factors in medulloblastoma1992